From the *Division of Brain Stimulation and Therapeutic Modulation, Department of Psychiatry, Columbia University/New York State Psychiatric Institute; and †Department of Electrical Engineering, Columbia University, New York, NY.
Received for publication January 12, 2010; accepted April 15, 2010.
Reprints: Angel V. Peterchev, PhD, 1051 Riverside Dr, Unit 21, New York, NY 10032 (e-mail: [email protected]).
This study was supported by NYSTAR Faculty Development Award (to S.H.L.), NARSAD Independent Investigator Award (to J.P.), NIH MH60884, NIH NCRR 5TL1RR024158-03.
A.V.P., Z.-D.D., and S.H.L. are inventors on Columbia University patent applications on TMS and MST technology. A.V.P. and S.H.L. have received equipment support from Magstim and MagVenture, TMS and MST device manufacturers. S.H.L. has received research grants from ANS/St Jude Medical, Neuronetics, Cyberonics, NIH, AFAR, NARSAD, Stanley Medical Research Foundation, DARPA, and NYSTAR.